Delivery Order SPE2DB20D1051-SPE2DB24FD9CZ

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S, with a ceiling value of $2,737.56 and a performance period ending on May 12, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication QULIPTA 60 MG TABLET 30S, with a ceiling value of $1,154.79 and a performance period through May 23, 2025. This contract is not set-aside and was awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,623.91, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024 and is a firm fixed-price delivery order. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 30 MG TABLET 30S. The award, valued at $1,237.79, has an ultimate completion date of September 3, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. The IDC enables the DLA to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a medical product, with a ceiling value of $7,633.22 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication QULIPTA 60 MG TABLET 30S, with a ceiling value of $1,154.79 and a completion date of June 23, 2025. The contract is a Firm Fixed Price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,675.35 and a period of performance through March 31, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,386.56, is for the supply of QULIPTA 60 MG TABLET 30S, a medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 2025. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of QULIPTA 30 MG TABLET 30S. The contract has a ceiling value of $1,154.79 and a completion date of May 16, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,745.47 and a performance period through April 11, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD9CZ
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract has a ceiling value of $2,680.52 and is for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S. This order is part of AmerisourceBergen's comprehensive IDC with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical commodities, including prescription drugs and supplies, to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation.

Generated 11/28/24, 9:35 AM